Biocon has plunged over 5% after reporting a 8.7% fall in Q1 net profit. The stock now trades at Rs 350, down 5.6%.
According to a release issued by Biocon to the NSE, net profit for the June quarter has declined to Rs 70.05 crore from Rs 76.74 crore in the quarter ended June 2010.
Further, consolidated net sales have dropped 33.3% to Rs 441.68 crore from Rs 662.28 crore.
Around 820,000 shares have changed hands at the counter on a combined basis so far on the both the exchanges.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app